ADR Ontology |
ADR Term |
Visceral leishmaniasis |
ADR ID |
BADD_A07822 |
ADR Hierarchy |
|
Description |
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH] |
MedDRA Code |
10047505 |
MeSH ID |
D007898; D007898; D007898
|
ADR Severity Grade (FAERS)
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
Synonym |
Kala-azar | L. infantum | L.donovani | Leishmania donovani infection | Leishmaniasis visceral (kala-azar) | Post kala-azar dermal leishmaniasis | Visceral leishmaniasis | Visceral leishmaniasis Mediterranean | Dumdum fever | Leishmaniasis, Visceral | Visceral Leishmaniasis | Kala-Azar | Kala Azar | Black Fever | Fever, Black |
|
|
ADR Related Proteins |
Protein Name |
UniProt AC |
TTD Target ID |
Not Available | Not Available | Not Available |
|
Drugs Leading to the ADR |
Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | BADD_D01418 | Methotrexate | 0.001960% | | BADD_D01507 | Mycophenolate mofetil | 0.001308% | | BADD_D02464 | Fingolimod | 0.001158% | |
The 1th Page 1
Total 1 Pages
|
|